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Abstract
Objective: Improving use of effective contraception to prevent unintended pregnancy is a global priority, but misperceptions
and concerns about contraception are common. Our objective was to evaluate an interactive website to aid informed choice
of contraception.
Methods: The Contraception Choices website is an interactive digital intervention which offers tailored advice to aid con-
traception decision-making (www.contraceptionchoices.org). In a parallel single-blind trial, we randomised 927 women
aged 15–30 years from six clinic settings to access the intervention website (n¼ 464) or to a waiting-list control group
(n¼ 463). The study was initially a feasibility trial, evolving into an evaluation of efficacy, with two primary outcomes at six
months: long-acting reversible contraception (LARC) use, and satisfaction with contraceptive method. Secondary outcomes
included self-reported pregnancy and sexually transmitted infection diagnoses. Free-text comments on the 3 and 6 month
outcome surveys were analysed thematically.
Findings: There was no significant difference between intervention and control groups in the proportion of women using
LARC [30.4% intervention versus 31.0% control; adjusted odds ratio 0.87 (95% confidence interval 0.60 to 1.28)]; satisfaction
with contraceptive method [82.6% versus 82.1%; adjusted ordinal odds ratio 0.93 (95% CI 0.69 to 1.25)]; self-reported
pregnancy [3.3% versus 4.1%; adjusted odds ratio 0.90 (95% CI 0.45 to 1.79)] nor sexually transmitted infection [5.3% versus
4.7%; adjusted odds ratio 0.72 (95% CI 0.55 to 2.36)]. Highly positive free-text comments from intervention participants
indicated that the website facilitates contraception choice and can help women feel better prepared before consultation
with healthcare providers.
Interpretation: The Contraception Choices website was popular for its design, trustworthy information and decision aids but
it was not associated with significant differences in use of LARC or satisfaction with contraceptive method. An interactive
website can aid contraception choice, but interventions that address factors beyond women’s control, such as access to
services, and partner, family or community influences are needed to complement this approach.
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Research in context: Preventing unintended pregnancy through effective use of contraception is essential for women’s
health, but choosing between different contraceptive methods can be challenging, and the opportunity for adequate
discussion during routine consultations is often constrained.
Evidence before this study: We conducted two systematic literature reviews: 1) Factors influencing contraception choice,
uptake and use: a meta-synthesis of systematic reviews; and 2) Effectiveness of interactive digital interventions (IDI) for
contraception choice, uptake and use. For the first review we searched PubMed, CDSR, Epistemonikos, DoPHER, DARE, NHS
Economic Evaluation Database, Campbell Library, NIHR Health Technology Assessment, and Health Evidence Canada
databases for systematic reviews which addressed contraceptive choice, uptake or use, from 2000 to 2017. PROSPERO
registration number: CRD42017081521 https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=81521. We syn-
thesised the findings of 18 systematic reviews of mostly moderate or high quality. They highlighted the importance of
women’s knowledge, beliefs, perceptions of side effects and health risks, as well as relationship status, social network,
economic and healthcare factors on contraception choice and use. For the second review, we searched 23 electronic
databases, trials registers and reference lists for randomised controlled trials of IDI for contraception, including
CENTRAL, MEDLINE, EMBASE, CINAHL, ERIC, ASSIA and PsycINFO, from start date to June 2017. PROSPERO registration
number: CRD42017081636. We found only five randomised trials of IDI, all from the USA. Risk of bias prevented synthesis of
results. www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=81636.
Added value of this study: Women’s common concerns about contraception – fear of hormones, weight gain, cancer,
infertility, mood changes, breaks from contraception and changes in bleeding patterns – underpinned development of a
new interactive website (www.contraceptionchoices.org). Contraception Choices addresses women’s concerns through suc-
cinct text; Q and A format (Frequently Asked Questions, Did you Know?; videos of women and health professionals); an
effectiveness infographic, and an interactive decision aid (What’s right for me?).
In an online randomised trial with 927 women attending clinics, we found no association of the Contraception Choices
intervention with the primary outcomes – satisfaction with contraceptive method and uptake of long-acting reversible
methods at 6 months. Nor did we find an association with secondary adverse outcomes – sexually transmitted infections
or pregnancy. Comments from women indicated that the website can meet young women’s need for information on the
benefits and drawbacks of contraception, help them to make informed decisions, and feel better prepared before healthcare
consultations. Contraception Choices is now available on the NHS website: www.nhs.uk/conditions/contraception/which-meth
od-suits-me
Implications of all the available evidence: Interactive digital interventions (websites) can aid contraception choice, but other
intervention research is needed to address wider influences on unintended pregnancy, including partner views, friends,
family, the media, wider society and experiences with healthcare professionals. Future research could examine the impact
of the website in different settings, e.g. schools or different countries. We hypothesise that use of the website during
contraceptive consultations might improve the efficiency or quality of consultation, for both patients and healthcare
providers. Appropriate methodology and time-scale for evaluating digital health interventions remains a key question.
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Contraception, contraceptive methods, interactive digital intervention, digital health, randomised controlled trial
Submission date: 26 June 2019; Acceptance date: 1 June 2020
Introduction
Control of fertility, and feeling satisfied with a chosen
method of contraception are crucial to the health and
wellbeing of women, but unintended pregnancy
remains common and costly for individuals and for
health services. Globally, about 40% of pregnancies
are estimated to be unplanned.1 In Britain, around
45% of pregnancies are unplanned or ambivalent2
despite a range of freely available effective contracep-
tive methods, and abortion rates in England and Wales
have changed little since 2011.3
Preventing unintended pregnancy involves many
steps, including timely education, awareness and social-
ly influenced behaviours to seek, choose and use
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contraception consistently and correctly.4 Health serv-
ices have a key role to play by supporting people to
choose and use an appropriate method that best meets
their needs, but many people are not aware of the range
of different methods available to them.5,6 The contra-
ceptive pill and condoms are well known and widely
used, but are not the most effective contraceptive meth-
ods. Long-acting reversible contraception (LARC),
which includes intrauterine devices, intrauterine sys-
tems, implants and injections, are at least 20 times
more effective than oral contraceptive pills and con-
doms7,8 but these methods are less well known, and
not all services have the capacity to fit them.9
Increasingly women turn to online sources of infor-
mation on sexual health,10 but information is of vari-
able quality and accuracy11 and misperceptions about
contraception are common.12 Hormonal contraception
methods have many potential benefits apart from con-
trol of fertility, including treatment of acne, reduced
period pain, lighter periods or no withdrawal bleeds,
and reduction in premenstrual symptoms,13 but women
may be more aware of risks and side effects than bene-
fits of contraception.12
Interactive (tailored) digital interventions are effec-
tive for increasing contraception knowledge14 uptake
of more effective contraceptive methods and contracep-
tion adherence,15–17 and decreasing unplanned preg-
nancy.18,19 Digital interventions offer the advantages
of intervention content accuracy and fidelity, and the
potential to reach large audiences with relatively low
dissemination costs.20 We therefore developed an inter-
active website to aid informed choice of contraceptive
method and then conducted a randomised controlled
trial to evaluate its impact in clinic populations.
Aim
To assess the efficacy of the Contraception Choices web-
site in comparison with control (waiting list) on uptake
of long-acting contraceptive methods, and satisfaction
with method choice in young women.
Methods
We conducted an individually randomised, parallel
group-controlled trial that started as a feasibility trial
and ended as an efficacy (clinical) trial. Approval was
given by London Camden & Kings Cross Research
Ethics Committee (Reference 17/LO/0112).
Summary of intervention development
We conducted two systematic reviews of the literature to
generate the evidence base for the website: a review of
reviews of factors influencing contraception choice and
use and a review of interactive digital interventions for
contraception. To gain the views of contraceptive users,
we recruited women from sites in London that represent
the settings in which the great majority of contraceptive
care occurs in the UK:21 a general practice, two sexual
health centres, an abortion clinic, a community pharma-
cy and an antenatal clinic. Eligibility criteria were
women aged 15–30 years, ability to give informed con-
sent, and interest in taking part in contraceptive
research. We conducted focus groups and individual
interviews to explore the views of 74 young women relat-
ing to contraception (access, acceptability, barriers, con-
cerns, benefits and personal decisions around choices)
and their views on website design and content. Working
iteratively with the young women and a commercial
software company (Moore Wilson), we synthesised the
findings from the systematic reviews and qualitative
research with women’s views to develop a trial-ready,
self-guided website offering tailored advice.
Intervention
The Contraception Choices website offers tailored
information to help users to decide which method of
contraception might suit them best, to facilitate
informed choices, satisfaction with choice, and uptake
of more effective methods (Logic Model, supplementa-
ry material). Contraception Choices provides informa-
tion about contraception: videos of women and health
professionals discussing contraceptive experiences, con-
cerns and misperceptions; an infographic representing
contraception effectiveness; Did you Know? and
Contraception FAQ sections which address common
concerns, and an interactive decision tool What’s
right for me? (See Supplementary file: Screenshots).
The What’s right for me? tool (Figure 2) elicits seven
individual priorities concerning contraception attrib-
utes. For example, selecting ‘Regular periods’ high-
lights methods compatible with regular periods
(simultaneously fading out those that can alter the
menstrual cycle) and the algorithm scores the highlight-
ed methods more highly. Three methods most consis-
tent with the individual’s preferences are displayed and
compared side-by-side, and the user can export their
results by email or text message. www.contracep
tionchoices.org (Figure 1a and Figure 1b).
The website content and design is underpinned by a
number of different theoretical principles including the
following:
• Human-centred design and collaboration with target
users– we involved target users in content and design
decisions, to ensure that content met young women’s
needs, priorities and preferences.20
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• Tailoring – the What’s right for me? decision tool
offers tailored information on contraception
method choices to increase relevance for more effec-
tive learning, engagement, and behaviour change.22
• Health belief model – the Effectiveness infographic
addresses perceptions of risk of pregnancy, showing
the relative effectiveness of different contraception
methods.
• Social cognitive theory – Contraception Choices
videos draw on the influence of peers by featuring
young women discussing their experiences of contra-
ception including the potential benefits of different
methods.
• The COM B model: capability, opportunity,
motivation-behaviour model23 – this takes into
account factors which are on pathways to behaviour
change.
• A social determinants of health framework24 under-
pins the design of two infographics which convey
barriers to contraception use across different
domains: individual women, partners, family,
peers, community, health services and wider society.
Participants
Inclusion criteria: women aged 15–30 years with a cur-
rent or future need for contraception, attending one of
the study sites, able to read English, with an active
email account and access to the internet and willing
to be followed up for 6 months. Exclusion criteria:
unable to provide informed consent (e.g. severe learn-
ing difficulties) or need for a language advocate
(because the intervention was intended to be accessed
in private). At the sites described above, women wait-
ing for their appointment (or in the pharmacy) were
approached by a researcher with a ‘tablet’ computer
and invited to take part in the trial. Women recruited
via the online booking system were sent a text message
inviting them to view the Contraception Choices website
before their booked appointment. Those who expressed
interest were recruited online via the tablet computer
using software designed specifically for this trial, to
confirm eligibility and register informed consent.
Procedures
Participants were asked to complete a short question-
naire at baseline which included demographic data
(age, ethnicity, highest completed level of education)
and whether English was their first language; current
use of contraception, or reasons for non-use (including
being pregnant); contraception method; from where the
method was obtained, and whether it was free or paid
for; satisfaction with current contraception (very satis-
fied, satisfied, neither satisfied or dissatisfied, dissatis-
fied and very dissatisfied); ever used contraceptive
methods (same list as current use); and self-reported
sexually transmitted infections in the last 3 months.
Automated, computerised randomisation occurred
immediately after baseline data collection.
Randomisation and masking
A randomisation list was generated by a random
number based algorithm in the computer software
Stata25 and incorporated into the trial software
Figure 1a. Contraception Choices website: home page.
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programme to allocate all participants to either the
intervention or control group. The randomisation list
was stratified by setting and used varying block sizes.
Allocation was immediate (online) and concealed.
Those randomised online to the intervention group
gained access to the Contraception Choices website
immediately; women randomised to the control group
could access the website at the end of data collection, at
which point we emailed them with a link to the website.
At 3 and 6 month follow-up, participants were
emailed a short online survey asking what method of
contraception they were using (including none) and
how satisfied they were with the method; whether
they had had a pregnancy and, if so, the outcome of
the pregnancy (ongoing, gave birth, miscarried, termi-
nated, or prefer not to say); and self-reported sexually
transmitted infection in the previous 3 months.
All participants were asked whether they had visited
the Contraception Choices website (control participants
were asked in order to assess ‘contamination’) and
asked a free-text question: “Has being in the study
had any good or bad effects on your life?”
Intervention group participants only were asked fur-
ther questions about the website: how helpful it was
in terms of ‘getting useful information about contra-
ception’ and ‘finding a method of contraception that is
right for you’ (five response options from very helpful
to very unhelpful); whether they had discussed the
Figure 1b. Contraception Choices website: What’s right for me?
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website with anyone (including a doctor or nurse, phar-
macist, partner, family or friends) and “What did you
like or dislike about the website?” (as a free-text
question).
Participants were sent electronic vouchers for com-
pleting follow-up surveys (£5 for the 3 month survey,
£15 for the 6 month survey). All follow-up emails
included a link to enable participants to withdraw
from the study, including one sent immediately after
enrolment.
The analysis of the primary outcomes was con-
ducted blinded to allocation.
Outcomes – original feasibility trial
The primary outcome for the initial feasibility trial was
follow-up rate at 6 months. Secondary outcomes at 6
months were: effectiveness of contraceptive method
used, grouped from least to most effective as follows:
no method, withdrawal or natural method, condoms or
diaphragm, pill, patch or ring, LARC or sterilisation;
change in effectiveness of method between baseline and
6 months; pregnancy and sexually transmitted
infection.
Outcomes – efficacy trial
As we were developing Contraception Choices, its pop-
ularity with young women became very evident.
Moreover, our presentations of the website to col-
leagues were met with demand to use it immediately
in clinical practice. Future funding for a definitive
trial was highly uncertain and withholding the website
for a number of years, in order that a definitive trial
with a control group of women who had not seen the
website might be funded and completed, felt unpalat-
able. Fortunately, the opportunity arose to increase
recruitment at minimal cost (see below) and so we
were able to expand the feasibility trial into an efficacy
trial by substituting the primary outcome (follow-up
rate at 6 months) for two primary clinical outcomes
that were originally secondary outcomes – use of
LARC at 6 months and satisfaction with contraceptive
method at 6 months. (We pre-specified that we would
consider the trial to have demonstrated superiority of
the intervention if a statistically significant benefit were
observed for one or both outcomes without clear evi-
dence of harm for either). Secondary outcomes were
effectiveness of contraceptive method at 6 months;
change in method from baseline to 6 months; pregnan-
cy by 6 months and diagnosed sexually transmitted
infection reported at 3 or 6 months.
To increase recruitment for the efficacy trial, we
took advantage of an online booking system for
appointments at one site (sexual and reproductive
health clinic) by adding a hyperlink about the trial
into the text message that women received to confirm
their contraception clinic appointment. Clicking on the
hyperlink took them directly to the trial website for
recruitment and randomisation.
Data analysis
The original target sample size for the feasibility trial
was 80 participants per setting, based on estimating a
follow-up rate at 6 months of 70% to within 10% pre-
cision (95% CI 60% to 80%) for each setting.
Changing the design to a clinical efficacy trial resulted
in a total sample size of 930 participants, based on the
power to assess the effect of the intervention on the
revised primary outcome, use of LARC at 6 month
follow-up. Specifically, assuming a follow-up rate of
70%, this sample size provides at 82% power to
detect as significant (at the 5% level) an increase
from 35% (control group prevalence) to 47% in
LARC use in the intervention group. No formal
sample size calculation was made for the other primary
outcome. The standard 5% significance level was taken
because although there are two primary outcomes we
use results from both to assess whether the intervention
is beneficial.
The primary analysis was by modified intention-to-
treat, basing analysis on those who completed at least
one follow-up outcome questionnaire. For each prima-
ry and secondary outcome listed earlier we present the
percentage of participants if the outcome is binary (e.g.
use of LARC) or ordinal (e.g. effectiveness of method,
satisfaction with method) together with a 95% confi-
dence interval. These percentages and means are
reported separately by intervention and standard care
arm. To formally assess differences between arms we
used logistic regression (for binary outcomes), or ordi-
nal logistic regression (for ordinal outcomes), reporting
adjusted odds ratios with 95% confidence intervals.
The primary outcome of LARC use at 6 months was
analysed among women in need of contraception (i.e.
not pregnant or currently trying to become pregnant)
and the primary outcome of satisfaction with method
was analysed among women who were using a method
at 6 months. The primary outcome of LARC use at 6
months was analysed stratified by LARC use at base-
line, leading to three intervention effects: the effect in
baseline LARC users, the effect in baseline non-users,
and the overall effect adjusted for baseline LARC use.
We pre-specified that if fewer than 90% of baseline
LARC users in the control arm are using a LARC
method at 6 months, then the primary effect measure
would be the overall adjusted intervention effect, and
otherwise (due to limited scope for increase in baseline
LARC users) the primary effect measure would be the
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effect in baseline non-users only. Besides adjustment
for baseline LARC use, analysis of both primary out-
comes was also adjusted for satisfaction with method at
baseline and by setting. A further subgroup analysis,
based on testing an interaction term, was conducted for
both primary outcomes to assess whether the effect of
the intervention varies by setting (specifically between
online and in-person recruitment). Comparisons for the
primary outcomes between arms were based on multi-
ple imputation where the primary outcomes at 6
months were imputed based on the outcomes at 3
months for participants who completed the 3 month
outcome questionnaire but failed to complete the ques-
tionnaire at 6 months. Imputation was conducted using
the chained equations approach and implemented
using the mi impute function,10 twenty imputed data-
sets were generated. Considering our secondary out-
comes, analysis of contraceptive effectiveness was
restricted to women in need of contraception at 6
months, reporting of a change in method was restricted
to women in need of contraception at both baseline and
6 months, and analysis of pregnancy at 6 months was
restricted to women who were not pregnant or trying
for a baby at baseline. All analysis was conducted in
Stata 15 software.
A post hoc decision was made to conduct a ‘per-
protocol’ analysis for the primary outcomes based on
a comparison of intervention arm participants who
reported seeing the Contraception Choices website
with all control arm participants.
All free-text comments from the 3 month and 6
month trial follow up surveys were imported into
NVIVO software, and coded. We used thematic anal-
ysis to identify patterns and links across the data set.
Two researchers (AG and JAS) independently coded
the data, categorised data by theme, and identified rela-
tionships between concepts to develop a coding
frame. Coding decisions were reviewed by a third
researcher (JB).
Role of the funding source
The funding source had no role in the writing of the
manuscript or the decision to submit it for publication.
Results
Recruitment and follow-up
The first participant was randomised on 4 July 2017
and the last on 22 December 2017. The first recruitment
through the online booking service was on 31 October
and the last on 22 December 2017. Recruitment online
was much faster than in the clinics. It took approxi-
mately 6 months to recruit 419 women from the clinic
sites, and just over seven weeks to recruit 508 women
via the online booking system (Table 1).
The last follow-up survey was completed on 16
August 2018. The CONSORT diagram (Figure 2)
details the flow of participants through the trial. In
total, 927 women were randomised to the website
(n¼ 464) or to control group (n¼ 463) of whom 739
(80%) provided follow-up data at 6 months, and 786
women (86%) provided data at 3 and/or 6 months for
analysis of primary outcomes with imputation.
Follow-up rates were similar across all sites (data
not shown) except for the abortion service, where the
follow-up rate was only 50%. The quality of the follow
up survey data collected was very high, with all
respondents providing the primary outcome data.
Eighteen (2%) women (11 in the intervention group
and 7 in the control group) withdrew from the trial
without offering reasons but they did not request that
their data be withdrawn from analysis.
The proportion of women who reported that they
had seen the Contraception Choices website at any time
during the trial was 86% in the intervention group and
7% in the control group, indicating good exposure in
the intervention group and little ‘contamination’ in the
control group.
Baseline data
Just over two-thirds of participants were from White
ethnic groups, half were educated to degree level and
four-fifths reported English as their first language
(Table 1). Ten percent were pregnant at enrolment,
while 90% indicated a current need for contraception
to avoid unintended pregnancy. The most common
method reported at baseline was the oral contraceptive
pill at 39.5% (n¼ 167) in the intervention group and
34.6% (n¼ 146) in the control group, followed by
LARC methods (Table 1). Around two-thirds of
women were satisfied with their current method at
baseline. (Only one woman reported being sterilised
at baseline; she is not included in subsequent analysis
because she did not complete a follow-up.)
Primary outcomes
There were no significant difference between interven-
tion and control groups in the proportion of women
using LARC at 6 months [30.4% intervention versus
31.0% control; adjusted odds ratio after imputation
0.87 (95% confidence interval 0.60–1.28)], or in level
of satisfaction with contraceptive method [proportion
being ‘satisfied’ or ‘very satisfied’ 82.6% intervention
versus 82.1% control; adjusted ordinal odds ratio after
imputation 0.93 (95% CI 0.69–1.25) based on the five
ordered responses].
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Table 1. Baseline characteristics by study arm.
Characteristic, % (n)
Intervention,
N¼ 464
Control,
N¼ 463
Site of recruitment
Sexual and reproductive health clinic 8.6 (40) 8.4 (39)
General practice 7.3 (34) 8.2 (38)
Abortion service 4.5 (21) 4.8 (22)
Maternity service 8.4 (39) 8.6 (40)
Community pharmacy 6.9 (32) 7.1 (33)
Sexual Health clinic for young people 8.8 (41) 8.6 (40)
Direct online booking (for the SRH clinic above) 55.4 (257) 54.2 (251)
Demographic factors
Age, median (IQR) 24 (21–27) 24 (21–27)
Ethnicity
White 67.0 (306) 71.0 (326)
Mixed 11.6 (53) 10.5 (48)
Asian 10.3 (47) 8.1 (37)
Black 9.0 (41) 8.3 (38)
Other 2.2 (10) 2.2 (10)
First language
English 80.8 (375) 84.2 (390)
Not English 19.2 (89) 15.8 (73)
Highest completed level of education
Degree 51.3 (238) 49.9 (231)
Diploma in higher education 10.6 (49) 9.7 (45)
A/AS levels 21.3 (99) 23.5 (109)
O levels / GCSE 9.7 (45) 7.8 (36)
Other 5.4 (25) 5.8 (27)
None 1.7 (8) 3.2 (15)
Contraception factors
Need for contraception
(continued)
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Around half of the participants in each group changed
their method of contraception between baseline and 6
months; themost common changewas to amore effective
method (24% intervention group; 21% control) but 19%
in the intervention group and 16% in the control group
changed to a less effective method (Table 2). Among
women who were using LARC at baseline, the propor-
tion using LARC at 6 months was significantly higher in
the control group than the intervention group (Table 2).
Among participants not using LARC at baseline, there
was a non-significantly higher proportion using LARCat
6 months in the intervention group. Across both study
arms, satisfaction with method of contraception
improved from around two-thirds at baseline to
four-fifths at follow-up. There was no difference between
groups in the proportion of womenwhowere pregnant at
6 months (among women who were neither pregnant nor
trying for a baby at baseline) or the proportion who
reported a diagnosed sexually transmitted infection
(STI) at 3 or 6 months (Table 2).
The effects of the intervention on the primary
outcomes did not vary significantly between online
and in-person recruitment (data not shown). Post
hoc, per-protocol analysis of the primary outcomes
was not appreciably different to the modified
intention-to-treat analysis (Table 3).
Women’s views of the Contraception Choices website
Of the 364 intervention participants with 6-month
follow-up data, 309 (85%) reported seeing the
Contraception Choices website. Of those, 97% found
it helpful or very helpful for “getting useful informa-
tion about contraception” and 87% responded that it
was helpful or very helpful for “finding a method of
contraception that is right for you.”
Over 91% (423/464) of intervention participants
provided free-text comments about the website in
follow-up surveys. Comments were strikingly positive,
Table 1. Continued.
Characteristic, % (n)
Intervention,
N¼ 464
Control,
N¼ 463
No – Pregnant 9.7 (45) 10.6 (49)
No – Trying for baby 0.2 (1) 0.2 (1)
Yes – Neither 90.1 (418) 89.2 (413)
Method used, if needed, ordered by efficacy
None 17.7 (74) 18.6 (77)
Unclear 0.2 (1) 0.5 (2)
Withdrawal/natural 0 (0) 1.2 (5)
Condom/diaphragm 10.5 (44) 11.1 (46)
Pill/patch/ring 42.6 (178) 39.0 (161)
LARC/sterilisation 29.0 (121) 29.5 (122)
Satisfaction with method, if using a method
Very dissatisfied 4.3 (15) 3.3 (11)
Dissatisfied 11.6 (40) 12.2 (41)
Neutral 16.2 (56) 17.2 (58)
Satisfied 36.4 (126) 32.6 (110)
Very satisfied 31.5 (109) 34.7 (117)
LARC: long-acting reversible contraception
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with praise for attractive website design, and the clarity
of information presented. Analysis of the free-text
comments indicated that the Contraception Choices
website helped to increase participant’s knowledge
about contraceptive methods and address their con-
cerns, helped with thinking about changing to a differ-
ent method, and feeling better prepared before clinic
appointments.
Knowledge about different methods
Women liked information which helped them to weigh
up the advantages and disadvantages of different
methods:
“Gives you the ups and downs about each choice and
also helps advise which one to choose.”
“I feel more clued up about potential contraception
choices which is great! I think far too many think
that the pill is the only way forward which is wrong!”
Tailored information
Women valued tailored feedback such as the What’s
right for me? decision aid, to help them to choose con-
traceptive methods to suit their priorities.
“It’s what I’ve always looked for, a clear way to com-
pare methods of contraception and find the best for
you. . . It may seem crazy, but it’s really hard to find
reliable and objective facts on contraception online.”
“I liked how easy it was to tailor a contraception to you
and that it considered things like not wanting a period.”
Concerns and misperceptions
Many women appreciated information which
addressed concerns and misperceptions, which was
not necessarily easy to find elsewhere:
“I was particularly interested in reading that you don’t
need a break from hormonal contraception.”
Considered eligible
(baseline started)
N = 965
Baseline completed
N = 948
Baseline not completed
N=17
Randomisation failure
N=6
(4 technical error &
2 incorrectly randomised to
both groups)
Correcty randomised
N = 927
Allocated to intervention
N = 464
Allocated to control
N=463
3 month FU
completed
N = 366
3 month FU
completed
N = 356
3 month FU
not completed
N = 97
3 month FU
not completed
N = 108
6 month FU
not completed
N = 65
6 month FU
not completed
N = 76
6 month FU
completed
N = 32
6 month FU
completed
N = 32
6 month FU
 not completed
N = 23
6 month FU
 not completed
N = 24
6 month FU
 completed
N = 343
6 month FU
 completed
N = 332
Total number of control particpants with 3 or 6 month FU completed
N = 398
Total number of intervention particpants with 3 or 6 month FU completed
N = 388
Randomised in error
N = 15
(15 aged ≥31years)
Figure 2. CONSORT diagram.
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Table 2. Comparison of outcomes between arms.
Outcome measures, % (n) Intervention Control
OR (CI), Intervention
vs. control
Adjusted
OR (CI)
Primary outcomes
LARC method in use at 6 months, overall N¼ 7131 30.4 (106) 31.0 (113) p¼ 0.74
0.95 (0.69–1.30)
p¼ 0.48
0.87 (0.60–1.28)6
If using LARC at baseline, N¼ 201 58.8 (57) 70.2 (73) p¼ 0.12
0.63 (0.35–1.12)
p¼ 0.024
0.46 (0.23–0.90)7
If not using LARC at baseline, N¼ 512 19.4 (49) 15.4 (40) p¼ 0.40
1.22 (0.77–1.92)
p¼ 0.49
1.18 (0.74–1.90)7
Satisfaction with method used at 6 months, N¼ 6242
Very dissatisfied 1.9 (6) 1.6 (5)
Dissatisfied 4.2 (13) 5.8 (18) p¼ 0.54 p¼ 0.62
Neutral 11.3 (35) 10.5 (33) 0.91 (0.68–1.22) 0.93 (0.69–1.25)6
Satisfied 39.9 (124) 35.5 (111)
Very satisfied 42.8 (133) 46.7 (146)
Secondary outcomes
Effectiveness of contraceptive method at 6 months, N¼ 7131
None 10.9 (38) 14.0 (51)
Withdrawal/natural 1.7 (6) 1.4 (5) p¼ 0.63 p¼ 0.33
Condom/diaphragm 12.6 (44) 12.1 (44) 1.07 (0.82–1.40) 1.15 (0.87–1.52)8
Pill/patch/ring 44.4 (155) 41.5 (151)
LARC/sterilisation 30.4 (106) 31.0 (113)
Change in method from baseline to 6 months, N¼ 6513
Change to more effective 23.8 (76) 20.5 (68)
Change to similarly effective 11.3 (36) 12.7 (42) N/A N/A
No change 46.3 (148) 51.1 (169)
Change to less effective 18.8 (60) 15.7 (52)
Pregnancy by 6 months, N¼ 6704 3.3 (11) 4.1 (14) p¼ 0.66
0.86 (0.43–1.69)
p¼ 0.76
0.90 (0.45–1.79)9
STI diagnosis reported at 3 or 6 months, N¼ 6245 5.3 (16) 4.7 (15) p¼ 0.76
1.12 (0.55–2.31)
p¼ 0.72
1.14 (0.55–2.36)9
LARC: long-acting reversible contraception
Analysis restricted to the following subgroups as indicated
1. Not pregnant or trying for baby at 6 months
2. Using a method at 6 months
3. Not pregnant or trying for baby at baseline or 6 months, clear reporting of method at both time points
4. Not pregnant or trying for baby at baseline
5. Completed 3 and 6 month questionnaire items
Adjusted for the following baseline factors as indicated
6. LARC use, satisfaction with method, and setting
7. satisfaction with method and setting
8. effectiveness of method, satisfaction with method, and setting
9. effectiveness of method
“It’s cleared up some of my doubts and things I wor-
ried about (probably unconsciously!) about hormonal
contraception.”
“Really useful, accessible information covering con-
cerns that you wouldn’t normally see on a medical
website, like. . . specifically stopping periods.”
Prompting changes of contraceptive method
Several participants discussed their intention to change
or consider swapping to a new method as a result of
what they had learned or seen on the website. Of those
who commented, all were thinking of switching to a
more effective long-acting reversible contraceptive
method.
“I think it’s (the website) got me thinking more about
which contraception I should use. I’m quite happy with
my pill and currently not sexually active, but I do think
I would like to switch to a LARC if I am in a relation-
ship again.”
Feeling empowered to speak to health
professionals and more prepared before clinic
appointments
Many participants reported feeling more empowered to
speak to healthcare professionals about contraception
and feeling better prepared for appointments to discuss
contraception:
“It has made me feel more confident. Prior I didn’t
really have anyone to speak to about contraception
and I didn’t feel comfortable discussing it with my
doctors so this bridged the gap.”
“It has led to an increased conversation with my GP
practice regarding suitable alternative methods to the
combined pill.”
“I think it’s really good to go in [to an appointment]
prepared with what you’ve looked at and have an idea
in your head before you make a decision about it.”
Barriers to accessing chosen contraception
methods
Although some participants wanted to change to a
more effective method of contraception, there were a
number of reported barriers to accessing contraception.
“I wanted the coil but I found it difficult to find some-
one to fit it in London.”
“Long waiting times. GP did not offer the services to
get implant fitted. Lack of sexual health clinics in my
area means very long waiting times.”
Table 3. Post hoc per-protocol analysis of primary outcomes.
Outcome measures, % (n)
Intervention
(seen website) Control (all)
OR (CI), Intervention
vs. control
Adjusted
OR (CI)*
LARC method in use at 6 months, N¼ 6601 31.4 (93) 31.0 (113) p¼ 0.86
1.03 (0.74–1.44)
p¼ 0.98
0.99 (0.66–1.49)
Satisfaction with method used at 6 months, N¼ 5782
Very dissatisfied 1.1 (3) 1.6 (5)
Dissatisfied 4.2 (11) 5.8 (18) p¼ 0.87 p¼ 0.95
Neutral 10.9 (29) 10.5 (33) 0.97 (0.72–1.33) 1.01 (0.74–1.39)
Satisfied 39.3 (104) 35.5 (111)
Very satisfied 44.5 (118) 46.7 (146)
LARC: long-acting reversible contraception.
Analysis restricted to the following subgroups as indicated.
1. Not pregnant or trying for baby at 6 months.
2. Using a method at 6 months.
* Adjusted for LARC use at baseline, satisfaction with method at baseline, and setting.
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Neutral or negative comments
There were only 12 neutral or negative comments,
often from women who gave positive comments too,
such as:
“Positive: easy to navigate, clear concise bullet points
for advantages/disadvantages of each contraceptive
method. Negative: no information relating to contra-
ception as a treatment for endometriosis.”
Five negative comments were from women who
wanted more specific information about particular con-
traceptive methods, and one person sought information
about handling difficult conversations with general
practitioners.
Discussion
In this randomised trial of the Contraception Choices
website, we did not find significant differences between
intervention and control groups in use of LARC or
satisfaction with contraceptive method by 6 months.
There were no significant differences in reported
adverse effects, including pregnancy and STI diagno-
ses. The Contraception Choices website was very posi-
tively evaluated by young women, who indicated that it
helped them to learn about contraception, to think
about changing to a different method, and to feel
better prepared before clinic appointments. However,
difficulty accessing health services is an important bar-
rier to accessing chosen methods of contraception.
Globally, there are an estimated 1.7 billion women
of reproductive age (15–49 years).26 Ensuring access to
accurate information about contraception to facilitate
informed decisions about choice and use of contracep-
tion is an essential but challenging step towards pre-
vention of unintended pregnancy.27,28 This paper
describes the evaluation of Contraception Choices, an
interactive website to aid informed choice of contracep-
tion. The evidence base for the website came from
extensive systematic review of published literature
and empirical qualitative research with young women,
and the intervention is underpinned by behaviour
change theory. The evaluation method was unusually
rigorous for a website – according to recent NICE
guidance, a randomised trial is the standard reserved
for digital health technologies that aim to prevent and
manage disease.29
The women who took part in the trial broadly reflect
the ethnic diversity of London,30 the proportion of
graduates31 and the proportion of people whose main
language is English in the UK.32 At the outset, we did
not expect to complete an efficacy (Phase III) trial of
the website, but the demand for Contraception Choices
from service providers, combined with the opportunity
to rapidly expand recruitment and enlarge the trial, led
to the transition from a feasibility to an efficacy trial.
Aside from delays due to the lengthy process of obtain-
ing all research permissions, the study procedures over-
all worked well, the online trial processes were highly
efficient and the follow-up rate was good, with 86% of
participants providing primary outcome data at 3 or 6
months. Recruitment in person was completed within
the anticipated 6 months, but recruiting online (via the
online booking system) was much more efficient, being
faster and at no additional cost. Just over half of all
participants were recruited this way in less than eight
weeks.
Our study underscores other evidence that online
trials are an efficient and acceptable way to conduct
clinical trials of low-risk interventions.33 However,
choice of methodology and appropriate time-scale for
evaluating the impact of digital health interventions
remains a key question; guidance on evaluation of
complex interventions from the UK Medical
Research Council,34 for example, with its meticulous
but slow progression through development, feasibility,
evaluation and implementation, seems out of step with
the rapid pace of change in digital health.
Digital interventions such as Contraception Choices
can meet a need for convenient, trustworthy online
information and support for contraception decision-
making.35,36 Our findings clearly show that the website
was popular and well received by users and healthcare
providers. Given the strikingly positive feedback about
the website from women, the high level of intervention
engagement (over four-fifths viewed the website) and
low ‘contamination’ in the control group (only 7% of
the control group reported seeing the website), the lack
of difference in primary outcomes between groups was
surprising.
Possible reasons for the observed lack of impact
relate to the many influences on contraceptive use
which are beyond an individual woman’s control,4 for
example, the opinions of partners, peers, religious lead-
ers and the wider community,4,37 and barriers to
accessing services for a desired method, including dif-
ficulties in getting appointments, long waiting times
and a lack of services that can fit LARC methods.
Other possible explanations include needing longer
follow-up for intentions to translate into action; mea-
surement reactivity (i.e. the possible impact of asking
the control group about their contraception use); the
limitations of a broad outcome measure like ‘satisfac-
tion with method’; the possibility that both interven-
tion and control group were receiving high quality
clinical care; and nearly a third were already using
LARC methods at baseline so that the website could
not show an additional impact. With hindsight, we
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might have seen significant differences between groups
had we included intermediate outcomes, such as ‘feel-
ing better informed about choice of methods’ or ‘feel-
ing confident about discussing different contraceptive
methods with a health professional’, but ultimately,
clinically important outcomes are the number of
women using an effective contraceptive method that
they are happy with and the prevention of unwanted
pregnancy.
In terms of implementing digital health interven-
tions in NHS services, we found that directing patients
to the Contraception Choices website via an automated
text message to confirm a clinic appointment was
simple and effective, without additional cost. Offering
the link at the time of booking an appointment facili-
tates access to the website well before a contraceptive
consultation and some women commented that they
felt better prepared for their consultation as a result.
The Contraception Choices website was offered for self-
directed use before appointments (in clinic settings or
at home), but the website could also be jointly accessed
during consultations. For example, the three tailored
contraception options generated by theWhat’s right for
me? feature can be discussed with clinicians, and the
website can also be displayed on the health professio-
nal’s computer screen during consultations. In this
study, we did not aim to assess such a development
in clinical practice, but an area for future research is
to examine whether it could lead to more efficient or
satisfying consultations, for both patients and clini-
cians, with potentially better clinical or health service
outcomes.38 Electronic interventions for contraception
which offer tailored material, increased frequency of
intervention administration, and/or structured follow-
up with a healthcare provider appear important for
longer-term impact:35 high quality evidence is needed
on the effectiveness of different intervention designs,
and cost-effectiveness of different models of interven-
tion delivery.
Contraception Choices is currently attracting over
15,000 visits a month and is promoted via a link on
the NHS website39 which receives around 11 million
visits per year. The availability of the website on the
internet offers many possibilities for further use and
evaluation. In our systematic review, we found remark-
able consistency across the globe in factors influencing
contraception choice, uptake and use. With appropri-
ate adaptations, Contraception Choices may be of ben-
efit to populations in different settings (e.g. schools) or
different countries; we are currently exploring its utility
in Botswana, a country with advanced e-health capac-
ity and high HIV prevalence. We see a real opportunity
to use Contraception Choices with vulnerable popula-
tions, including those where information and education
to support effective use of contraception are scarce.
In conclusion, the Contraception Choices website
was very popular with young women for its attractive
design, engaging presentation of trustworthy informa-
tion, and guidance in choosing a method tailored to
individual preferences. However, we did not find any
significant difference in use of LARC or satisfaction
with contraceptive method at 6 months. Our systematic
reviews confirmed multiple factors affecting women’s
choice and use of contraception which go beyond
informed choice, such as the influence of others includ-
ing partners, friends, family, school, religion, wider cul-
ture and health services. The lack of effect on clinical
outcomes in this trial, despite highly positive feedback
from participants, highlights a gap between improving
delivery of personalised information and impact on
contraceptive use. An interactive website can address
individual barriers to contraception choice and use
such as lack of knowledge, concerns and misunder-
standings, but interventions at other levels are needed
to complement this approach.
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